Electroacupuncture and Rosiglitazone Combined Therapy as a Means of Treating Insulin Resistance and Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Aims. To evaluate the efficacy of rosiglitazone (TZD) and electroacupuncture (EA) combined therapy as a treatment for type 2 diabetes mellitus (T2DM) patients by randomized single-blind placebo controlled clinical trial. Methods. A total of 31 newly diagnostic T2DM patients, who fulfilled the study&...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Rong-Tsung, Pai, Huei-Chin, Lee, Yu-Chen, Tzeng, Chung-Yuh, Chang, Chin-Hsien, Hung, Pei-Hsiu, Chen, Ying-I, Hsu, Tai-Hao, Tsai, Chin-Chun, Lin, Jaung-Geng, Chang, Shih-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745852/
https://www.ncbi.nlm.nih.gov/pubmed/23983807
http://dx.doi.org/10.1155/2013/969824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745852/
https://www.ncbi.nlm.nih.gov/pubmed/23983807
http://dx.doi.org/10.1155/2013/969824

Ejemplares similares